3652 results for «231»

Filter By

3652 results

Treatment of in-stent restenosis

16 May 2023 – From EuroPCR 2023

Looking for a recap of this case-based session to refresh your memory? Don't miss these slides and review the diagnostic and management details of each case.

In-stent restenosis case

Endovascular management treatment

17 May 2023 – From EuroPCR 2023

In this series of resources, explore the toolbox for BTK bifurcation treatment with antegrade and retrograde management, navigate complex scenarios in superficial femoral artery and femoral bifurcation and  elevate your expertise in carotid artery stenting managment. 

Endovascular management treatment

Mitral and tricuspid valve intervention : new devices and clinical outcomes

17 May 2023 – From EuroPCR 2023

Need a reminder on this session about the new devices and clinical outcomes in mitral and tricuspid valve intervention? Take a look at these slides and review the essential in a glance.

Mitral and tricuspid valve intervention

Bifurcations

17 May 2023 – From EuroPCR 2023

Seeking to revive your understanding of this session focusing on bifurcations? Examine these slides and review the main elements of the presentations.

Bifurcations in interventional cardiology

Working in the cathlab makes everyday different

17 May 2023 – From EuroPCR 2023

Experience the dynamic cathlab environment, where each day brings unique challenges. These slides will cover diverse topics such as pulmonary ductus arteriosus, coronary artery fistula, TAVI with mechanical mitral valve, and much more!

Working in the cathlab makes everyday different

Novel treatment strategies in ACS patients

17 May 2023 – From EuroPCR 2023

Seeking to revive your understanding on novel strategies in ACS treatment? Explore this collection of resources to get insight on optimal antithrombotic therapy in AF patients post-PCI, complete revascularisation in ACS, and early invasive approaches in high-risk NSTEMI, among other topics. 

Novel treatment strategies in ACS patients

Coronary artery disease: more imaging, less imagination

18 May 2023 – From EuroPCR 2023

In these slides, explore associations between angiography-based FFR and OCT-detected luminal obstruction, prognostic impact of ischaemia vs. plaque vulnerability, CT's mortality foresight, and much more.

Coronary artery disease: more imaging, less imagination

TAVI 1: durability, mismatch and challenging anatomy

18 May 2023 – From EuroPCR 2023

Explore TAVI longevity: Five-year Portico valve outcomes, bioprosthetic dysfunction post-surgery or self-expanding TAVI, prosthesis-patient mismatch impact, and innovative valve-in-valve TAVI insights, and more.

TAVI 1: durability, mismatch and challenging anatomy

PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.

Join us in Tokyo from 13-15 February: Explore the Toranomon Hills Tower venue and stay updated on the best deals for flights and hotel accommodations.

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry

17 Sep 2022

Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Elad Asher

Author

Elad Asher
Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

EuroPCR 2026 – Long-term mortality following revascularisation for left main disease

20 May 2026

Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...

EuroPCR 2026 – Long-term mortality following revascularisation for left main disease

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG
Didn’t find what you were looking for?